Back to Search
Start Over
Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice.
- Source :
-
International journal of molecular sciences [Int J Mol Sci] 2025 Jan 29; Vol. 26 (3). Date of Electronic Publication: 2025 Jan 29. - Publication Year :
- 2025
-
Abstract
- Progestogens' anti-anxiety and anti-depressive effects and mechanisms are not well-understood. Progestogens are hypothesized to have anti-anxiety and anti-depressive effects on behavior, independent of actions at nuclear progestin receptors (NPRs) and dependent on allopregnanolone (5α-pregnan-3α-ol-20-one; 3α,5α-THP), a 5α-reduced, neuroactive metabolite of progesterone (P <subscript>4</subscript> ). Adult c57 mice in behavioral estrus (proestrus; pro) showed more anti-anxiety-like and anti-depressant-like behavior and higher levels of estradiol (E <subscript>2</subscript> ), P <subscript>4</subscript> , and allopregnanolone in the hippocampus/amygdala complex. Proestrus c57 > 5α-reductase knockout (5αRKO) mice made more central entries in an open field than diestrus c57 and 5αRKO mice that were not different. Ovariectomized (OVX) c57 mice administered 1, 2, or 4 mg/kg P <subscript>4</subscript> SC showed dosage-dependent increases in central entries in an open field (more anti-anxiety-like behavior); 5αRKO mice had maximal increases at 1-2 mg/kg P <subscript>4</subscript> . OVX c57 and 5αRKO mice showed maximum increases in central entries with SC 3α,5α-THP (4 mg/kg), and c57s showed a similar maximal response to P <subscript>4</subscript> (4 mg/kg), but 5αRKOs response was half at that dosage. P <subscript>4</subscript> (4 mg/kg SC to OVX c57 or progestin receptor knockout (PRKO) mice decreased immobility (depression-like behavior) in the forced swim task. Effects of E <subscript>2</subscript> and veh were similar in both groups. Levels of 3α,5α-THP in the hippocampus/amygdala were consistent with effects on central entries in the open field. Levels of brain-derived neurotrophic factor (BDNF) in the hippocampus/amygdala were greater among E <subscript>2</subscript> -primed (0.09 mg/kg, SC) vs vehicle-administered mice. In sum, adult female mice can be responsive to P <subscript>4</subscript> for anti-anxiety/anti-depressant-like behavior; such effects may be independent of NPRs but require 5α-reduction and E <subscript>2</subscript> 's priming actions at BDNF in the hippocampus/amygdala complex.
- Subjects :
- Animals
Female
Mice
Behavior, Animal drug effects
Mice, Inbred C57BL
Pregnanolone pharmacology
Pregnanolone metabolism
Antidepressive Agents pharmacology
Anti-Anxiety Agents pharmacology
Estradiol pharmacology
Estradiol metabolism
Ovariectomy
3-Oxo-5-alpha-Steroid 4-Dehydrogenase metabolism
3-Oxo-5-alpha-Steroid 4-Dehydrogenase genetics
Hippocampus metabolism
Hippocampus drug effects
Progesterone pharmacology
Progesterone metabolism
Mice, Knockout
Receptors, Progesterone metabolism
Receptors, Progesterone genetics
Brain-Derived Neurotrophic Factor metabolism
Brain-Derived Neurotrophic Factor genetics
Anxiety drug therapy
Anxiety metabolism
Depression drug therapy
Depression metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1422-0067
- Volume :
- 26
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- International journal of molecular sciences
- Publication Type :
- Academic Journal
- Accession number :
- 39940941
- Full Text :
- https://doi.org/10.3390/ijms26031173